Company profile
PanTarg
- Industry
- Pharmaceutical Manufacturing
- Employees
- 5
- Headquarters
- Copenaghen
- Founded
- 2024
- Office locations
- 1
PanTarg company summary
PanTarg is a company in the Pharmaceutical Manufacturing industry, headquartered in Copenaghen, founded in 2024. On LinkedIn the company has around 5 employees.
What technology does PanTarg use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About PanTarg
PanTarg is developing next-generation antibody-drug conjugates (ADCs) to treat some of the most aggressive cancers. Our lead program focuses on pancreatic cancer, one of the deadliest tumor types with very limited treatment options, while our approach holds broad pan-cancer potential. Our ADCs are designed with a dual-attack mechanism that targets both cancer cells and the tumor-supporting stroma. By dismantling the protective shield around tumors, we aim to improve treatment penetration, overcome resistance, and enhance therapeutic outcomes. PanTarg is a Danish biotech spin-out from Rigshospitalet and the University of Copenhagen, founded by researchers with extensive experience in ADC development. We are advancing a proprietary uPAR-targeted ADC through preclinical development with the ambition of delivering a transformative therapy to patients in need. PanTarg’s therapies are currently in development and are not yet available to patients.
Where is PanTarg located?
PanTarg lists 1 location.
Compare companies similar to PanTarg
More companies in Pharmaceutical Manufacturing.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
PanTarg pantarg.com | Pharmaceutical Manufacturing | 5 | 2024 | Copenaghen |
 Anacor Pharmaceuticals pfizer.com | Pharmaceutical Manufacturing | 108,102 | - | New York, New York |
 Sanofi sanofi.com | Pharmaceutical Manufacturing | 93,352 | - | Paris, France, FR |
 GSK gsk.com | Pharmaceutical Manufacturing | 92,179 | - | London, England |
 Novartis España novartis.com | Pharmaceutical Manufacturing | 85,373 | - | Basel, Baselstadt |
 AstraZeneca astrazeneca.com | Pharmaceutical Manufacturing | 80,667 | - | Cambridge, Cambridgeshire, GB |
 Eli Lilly and Company lilly.com | Pharmaceutical Manufacturing | 57,202 | - | Indianapolis, Indiana |
 Merck merck.us | Pharmaceutical Manufacturing | 44,794 | - | Rahway, New Jersey |
 SUN PHARMA sunpharma.com | Pharmaceutical Manufacturing | 47,764 | 1983 | Mumbai, Maharastra |
 Boehringer Ingelheim boehringer-ingelheim.com | Pharmaceutical Manufacturing | 47,150 | - | Ingelheim am Rhein, Rhineland-Palatinate |
 Cipla cipla.com | Pharmaceutical Manufacturing | 51,911 | - | Mumbai, Maharashtra |
Frequently asked questions about PanTarg
What does PanTarg do?
PanTarg is developing next-generation antibody-drug conjugates (ADCs) to treat some of the most aggressive cancers. Our lead program focuses on pancreatic cancer, one of the deadliest tumor types with very limited treatment options, while our approach holds broad pan-cancer potential. Our ADCs are designed with a dual-attack mechanism that targets both cancer cells and the tumor-supporting stroma. By dismantling the protective shield around tumors, we aim to improve treatment penetration, overcome resistance, and enhance therapeutic outcomes. PanTarg is a Danish biotech spin-out from Rigshospitalet and the University of Copenhagen, founded by researchers with extensive experience in ADC development. We are advancing a proprietary uPAR-targeted ADC through preclinical development with the ambition of delivering a transformative therapy to patients in need. PanTarg’s therapies are currently in development and are not yet available to patients.
How many employees does PanTarg have?
PanTarg has around 5 employees on LinkedIn.
Where is PanTarg headquartered?
PanTarg is headquartered in Copenaghen.
When was PanTarg founded?
PanTarg was founded in 2024.
Build a lead list from companies like PanTarg
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.